In-vitro susceptibility of fluconazole and amphotericin B against Candida isolates from women with vaginal candidiasis in Taiwan

Journal of Food and Drug Analysis

Volumn 13, Issue 1, 2005, Pages 12-16

  Tseng, Ya Hsiu ^a   Lee, Wen Tsung ^b   Kuo, Tsung Cheng ^b  

^a TRANSWORLD INSTITUTE OF TECHNOLOGY   (Taiwan)

^b KUO GENERAL HOSPITAL   (Taiwan)

Author keywords

Amphotericin B; Fluconazole; Susceptibility; Vaginal cadidiasis

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; TRIAZOLE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; SACCHAROMYCES CEREVISIAE; TAIWAN; VAGINA CANDIDIASIS;

BACTERIA (MICROORGANISMS); CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; SACCHAROMYCES CEREVISIAE; TRICHOMONAS;

EID: 20344399659     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Sobel, J. D., Faro, S., Force, R. W., Foxman, B., Ledger, W. J., Nyirjesy, P. R., Reed, R. D. and Summers, P. R. 1998. Vulvovaginal candidiasis: epidemiological, diagnostic, and therapeutic considerations. Am. J. Obstet. Gynecol. 178: 203-211.
2. Lanchares, J. L. and Hernandez, M. L. 2000. Recurrent vaginal candidiasis changes in etiopathogenical patterns. Int. J. Gynecol. Obstet. 71: S29-S35.
3. Guiot, H. F. L., Fibbe, W. E. and van't Wout, J. W. 1994. Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clin. Infet. Dis. 18: 525-532.
4. Nyirjesy, P., Seeney, S. M., Grody, M. H. T., Jordan, C. A. and Buckley, H. R. 1995. Chronic focal vaginitis: the value of cultures. Am. J. Obstet. Gynecol. 173: 820-823.
5. Sobel, J. D., Kapernick, P. S., Zervos, M., Reed, B. D., Hooton, T., Soper, D., Nyirjesy, P., Heine, M. W., Wollems, J., Panzer, H. and Wittes, H. 2001. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. Am. J. Obstet. Gynecol. 185: 363-369.
6. Sobel, J. D. and W. Chaim. 1996. Vaginal microbiology of women with acute recurrent vulvovaginal candidiasis. J. Clin. Microbiol. 34: 2497-2499.
7. Burgess, D. S., Hastings, R. W., Summers, K. K., Hardin, T. C. and Rinaldi, M. G. 2000. Pharmacodynamics of flucoznazole, itraconazole, and amphotericin B Candida albicans. Diag. Microbiol. Infect. Dis. 36: 13-18.
8. Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., vander Horst, C. M., Edwards, J., Washburn, R. G., Scheld, W. M., Karchmer, A. M., Dine, A. P., Levenstein, M. J. and Webb, C. D. 1994. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N. Engl. J. Med. 331: 1325-1330.
9. Rippon, J. W. 1974. The pathogenic fungi and the pathogenic actinomycetes. In "Medical Mycology". 1st ed. pp. 33-70. Philadelphia, Saunders.
10. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing for yeasts. Approved Standard M27-T. Villanova, PA: National Committee for Clinical Laboratory Standards.
11. Kent, H. L. 1991. Epidemiology of vaginitis. Am. J. Obstet. Gynecol. 165: 1168-1176.
12. Hsueh, P. R., Chen, M. L., Sun, C. C., Chen, W. H., Pan, H. J. and Yang, L. S. 2002. Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999. Emerg. Infect. Dis. 8: 63-68.
13. Chong, P. P., Lee, Y. L., Tan, B. C. and Ng, K. P. 2003. Genetic relatendness Candida strains isolated from women with vaginal candidiasis in Malaysia. J. Med. Microbiol. 52: 657-666.
14. Hospenthal, D. R., Murray, C. K. and Rinaldi, M. G. 2004. The role of antifungal susceptibility testing in the therapy of candidiasis. Diag. Microbiol. Infrct. Dis. 48: 153-160.
15. Saporiti, A. M., Gomez, D., Levalle, S., Galeano, M., Davel, G., Vivot, W. and Rodero, L. 2001. Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use. Rev. Argent Microbiol. 33: 217-22.
16. Bauters, T. G., Dhont, M. A., Temmerman, M. I. and Nelis, H. J. 2002. Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am. J. Obstet. Gynecol. 187: 569-74.
17. Otero, L., Fleites, A., Mendez, F. J., Palacio, V. and Vazquez, F. 1999. Susceptibility of Candida species isolated from female prostitutes with vulvovaginitis to antifungal agents and boric acid. Eur. J. Clin. Microbiol. Infect. Dis. 18: 59-61.
18. Sobel, J. D., Zervos, M., Reed, B. D., Hooton, T., Soper, D., Nyirjesy, P., Heine, M. W., Willems, J. and Panzer, H. 2003. Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications. Antimicrob. Agents Chemother. 47: 34-38.
19. Rex, J. H., Cooper, C. R., Merz, W. H., Galgiani, J. N. and Anaissie, E. J. 1995. Detection of amphotericin B-resistant Candida isolates in broth-based system. Antimicrob. Agents Chemother. 39: 906-909.
20. Masakazu, N., Nagai, Y., Niimi, K., Wada, S. I., Cannon, R. D., Uehara, Y. and Monk, B. C. 2002. Identification of two proteins induced by exposure of the pathogenic fungus Candida glabrata to fluconazole. J. Chromato. B 782: 245-252.
21. Spinillo, A., Capuzzo, E., Gulminetti, R., Marone, P., Colonna, L. and Piazza, G. 1997. Prevalence and risk factors for fungal vaginitis caused by non-albicans species. Am. J. Obstet. Gynecol. 176: 138-141.
22. Posteraro, B., Sanguinetti, M., D'Amore, G, Masucci, L., Morace, G. and Fadda, G. 1999. Molecular and epidemiological characterization of vaginal Saccharomyces cerevisiae isolates. J. Clin. Microbiol. 37: 2230-2235.
23. Nolte, F. S., Parkinson, T., Falconer, D. J., Dix, S., Williams, J., Gilmore, C., Geller, R., Wingard, J. R. 1997. Isolation and characterization of fluconazole and amphotericin B- resistant Candida albicans from blood of two patients with leukemia. Antimicrob. Agents Chemother. 41: 196-199.